BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35938163)

  • 1. Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury.
    Liu SB; Meng XM; Li YM; Wang JM; Guo HH; Wang C; Zhu BM
    Front Cell Dev Biol; 2022; 10():946484. PubMed ID: 35938163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A.
    Meng XM; Liu SB; Deng T; Li DY; You L; Hong H; Feng QP; Zhu BM
    J Cardiovasc Transl Res; 2023 Oct; 16(5):1032-1049. PubMed ID: 36947365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.
    Ang SY; Uebersohn A; Spencer CI; Huang Y; Lee JE; Ge K; Bruneau BG
    Development; 2016 Mar; 143(5):810-21. PubMed ID: 26932671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase KMT2D inhibits ENKTL carcinogenesis by epigenetically activating SGK1 and SOCS1.
    Zhang YH; Tao Q; Zhang WY; Zhao S; Liu WP; Gao LM
    Genes Genomics; 2024 Feb; 46(2):203-212. PubMed ID: 37523130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine methyltransferase Kmt2d regulates naive CD8
    Kim J; Nguyen T; Cifello J; Ahmad R; Zhang Y; Yang Q; Lee JE; Li X; Kai Y; De S; Peng W; Ge K; Weng NP
    Front Immunol; 2022; 13():1095140. PubMed ID: 36741385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.
    Yao B; Xing M; Meng S; Li S; Zhou J; Zhang M; Yang C; Qu S; Jin Y; Yuan H; Zen K; Ma C
    Adv Sci (Weinh); 2024 Jan; 11(2):e2302037. PubMed ID: 38015024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
    Li M; Shi M; Xu Y; Qiu J; Lv Q
    Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
    Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
    Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
    Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
    Ortega-Molina A; Boss IW; Canela A; Pan H; Jiang Y; Zhao C; Jiang M; Hu D; Agirre X; Niesvizky I; Lee JE; Chen HT; Ennishi D; Scott DW; Mottok A; Hother C; Liu S; Cao XJ; Tam W; Shaknovich R; Garcia BA; Gascoyne RD; Ge K; Shilatifard A; Elemento O; Nussenzweig A; Melnick AM; Wendel HG
    Nat Med; 2015 Oct; 21(10):1199-208. PubMed ID: 26366710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
    Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
    Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
    Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K
    Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Murugesan N; Maitituoheti M
    Mol Cell Oncol; 2021; 8(5):1984827. PubMed ID: 34859145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
    Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
    Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome.
    Zhang L; Pilarowski G; Pich EM; Nakatani A; Dunlop J; Baba R; Matsuda S; Daini M; Hattori Y; Matsumoto S; Ito M; Kimura H; Bjornsson HT
    Mol Ther Methods Clin Dev; 2021 Mar; 20():779-791. PubMed ID: 33738331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
    Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
    Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
    Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation.
    Dhar SS; Brown C; Rizvi A; Reed L; Kotla S; Zod C; Abraham J; Abe JI; Rajaram V; Chen K; Lee M
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
    Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
    Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.